Orphan Drugs Market Size To Expand at a Notable CAGR Of 9.20% During 2022-2030

Pune, India, March, 2019 /MRFR Press Release/- Market research future published a cooked research report on global Orphan drug market.

Market Highlights

The Orphan Drugs Market is expected to reach USD 355.00 billion by 2030 at 9.20% CAGR during the forecast period 2022-2030.

Based on drug type, the biologics segment accounted for the largest market share in 2017, with a market value of USD 75,103.32 million. Orphan drugs are defined as those intended for effective treatment, diagnosis, or prevention of rare disorders that affect more than 200,000 people worldwide. There are two types of orphan drugs such as biologics and non-biologics. The rising focus of pharmaceutical companies on orphan drug improvement, the increasing prevalence of rare diseases and government initiatives for orphan medicine are some factors favoring market growth. Various other factors such as growth in the biotechnology and pharmaceutical sector, growing awareness about the rare disease and improving regulatory framework are continuously contributing to the growth of the global orphan drugs market. However, stringent FDA regulation, lack of specificity and poor healthcare systems in low- and middle-income countries may hamper the growth of the market. 

Segment analysis

The global orphan drugs market is segmented into drug type, sale, drug, and therapy class. 

On the basis of drug type, the global orphan drugs market is further sub-segmented as biologics and non-biologics. The biologics segment accounted for the market value of USD 75,103.32 million in 2017.

By sale, the global orphan drugs market has been sub-segmented into generics and prescribed.

Based on drug, the global orphan drugs market has been sub-segmented into Revlimid, Rituxan, opdivo, keytruda, Imbruglia, Soliris, jakaf, pomalyst, darzalex, spinraza, adcetris.

The global orphan drugs market, by therapy class, has been sub-segmented into oncology, blood, central nervous systems, endocrine, cardiovascular, respiratory.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Orphan Drugs Market Research Report

Regional Analysis

Geographically, the global orphan drugs market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, The Americas accounted for the largest market share of 39.98% in 2017, with a market value of USD 46,576.1 million, the market is expected to register a CAGR of 11.04% during the forecast period. Europe was the second-largest market in 2017. However, the market in Asia-Pacific is expected to register the highest CAGR.

Key Findings of the Study:

• Global orphan drugs market is projected to reach over USD 2,23,646.51 million by 2023 with 11.50 % CAGR during the review period of 2018 to 2023


• The Middle East and Africa holds the lowest share in the global orphan drugs market due to low development, lack of technical knowledge, and poor medical facilities.


• Based on drug type the biologics segment holds the largest market value of USD 75,103.32 million in 2017.


• Some of the players operating in the global orphan drugs market are F. Hoffmann-La Roche AG, Mylan, Celgene Corporation, Novartis AG, Biogen, Takeda Pharmaceutical Company Limited, Merck KGaA, Eli Lilly and Company, Shire Pharmaceutical, Sanofi, Janssen Global Services LLC, Alexion Pharmaceuticals Inc., Vertex Pharmaceuticals Inc., Pfizer Inc., Bristol Meyer Squibb.

This research report provides the insights, on various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Orphan Drugs Market, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com